Hospital Duran i Reynals,
L’Hospitalet de Llobregat
Investigación
Traslacional
en Cáncer de
Cabeza y Cuello
2026-2027
para pacientes y familiares
👇🏼 Encouraging antitumor activity of subcutaneous amivantamab in recurrent/metastatic head and neck squamou... https://www.sciencedirect.com/science/article/pii/S1368837525006207 @ttccgroup
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311 | JCO Oncology Advances
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–As...
PURPOSEThe ECOG-ACRIN E3311 phase II trial demonstrated outstanding disease control (90.6% 54-month progression-free surviva...
ascopubs.org
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine Phosphate in Patients With Recurrent Head and Neck Cancer | JCO Oncology Advances
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine...
PURPOSEAd/PNP (Gedeptin) is a nonreplicating adenoviral vector expressing E. coli purine nucleoside phosphorylase (PNP) fo...
ascopubs.org
👇🏼 Encouraging antitumor activity of subcutaneous amivantamab in recurrent/metastatic head and neck squamou... https://www.sciencedirect.com/science/article/pii/S1368837525006207 @ttccgroup
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311 | JCO Oncology Advances
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–As...
PURPOSEThe ECOG-ACRIN E3311 phase II trial demonstrated outstanding disease control (90.6% 54-month progression-free surviva...
ascopubs.org
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine Phosphate in Patients With Recurrent Head and Neck Cancer | JCO Oncology Advances
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine...
PURPOSEAd/PNP (Gedeptin) is a nonreplicating adenoviral vector expressing E. coli purine nucleoside phosphorylase (PNP) fo...
ascopubs.org
👇🏼 Encouraging antitumor activity of subcutaneous amivantamab in recurrent/metastatic head and neck squamou... https://www.sciencedirect.com/science/article/pii/S1368837525006207 @ttccgroup
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311 | JCO Oncology Advances
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–As...
PURPOSEThe ECOG-ACRIN E3311 phase II trial demonstrated outstanding disease control (90.6% 54-month progression-free surviva...
ascopubs.org
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine Phosphate in Patients With Recurrent Head and Neck Cancer | JCO Oncology Advances
Phase I/II Study of Intratumoral Ad/Purine Nucleoside Phosphorylase (Gedeptin) With Fludarabine...
PURPOSEAd/PNP (Gedeptin) is a nonreplicating adenoviral vector expressing E. coli purine nucleoside phosphorylase (PNP) fo...
ascopubs.org

